France (FR)

Au/TiO2(P25)-gC3N4 composites with low gC3N4 content enhance TiO2 sensitization for remarkable H2 production from water under visible-light irradiation (2020) Jiménez-Calvo P, Caps V, Ghazzal MN, Colbeau-Justin C, Keller V Journal article Clinical data, limitations and perspectives on chimeric antigen receptor T-cell therapy in multiple myeloma (2020) Beauvais D, Danhof S, Hayden PJ, Einsele H, Yakoub-Agha I Journal article, Review article Predictors of Access to Rehabilitation in the Year Following Traumatic Brain Injury: A European Prospective and Multicenter Study (2020) Jacob L, Cogne M, Tenovuo O, Roe C, Andelic N, Majdan M, Ranta J, et al. Journal article A beta-barrel for oil transport through lipid membranes: Dynamic NMR structures of AlkL (2020) Castiglione K, Schubeis T, Marchand L, Daday C, Kopec W, Movellan KT, Stanek J, et al. Journal article 3D Morphable Face Modelsa-Past, Present, and Future (2020) Egger B, Smith WAP, Tewari A, Wuhrer S, Zollhoefer M, Beeler T, Bernard F, et al. Journal article Characterization of Carbon Materials for Hydrogen Storage and Compression (2020) Sdanghi G, Canevesi RLS, Celzard A, Thommes M, Fierro V Journal article, Review article Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy (2020) Girard N, Fietkau R, Garassino M, Garrido P, Field JK, Peters S, Smit HJM, et al. Conference contribution EPIK-B3: A phase III, randomised, double-blind (DB), placebo (PBO)-controlled study of alpelisib (ALP) plus nab-paclitaxel (nabPTX) in advanced triple-negative breast cancer (TNBC) with either PIK3CA mutation or phosphatase and tensin homolog (PTEN) loss without PIK3CA mutation (2020) Sharma P, Farooki A, Fasching P, Loi S, Peterson K, Prat A, Tripathy D, et al. Conference contribution Efficacy and safety of lanreotide autogel (LAN) 120 mg every 14 days in progressive pancreatic or midgut neuroendocrine tumours (NETs): CLARINET FORTE study results (2020) Pavel ME, Cwikla JB, Lombard-Bohas C, Borbath I, Shah T, Pape UF, Thanh XMT, et al. Conference contribution Clinical characteristics and outcomes of coronavirus 2019 disease (COVID-19) in cancer patients treated with immune checkpoint inhibitors (ICI). (2020) Rogiers A, Tondini C, Grimes JM, Trager MH, Nahm S, Zubiri L, Papneja N, et al. Conference contribution